Electrome Bioelectric Therapeutics Platform being used to explore inhibition of pathogen motility and persistence, with implications for infectious ...
Electrome Corporation, a unique biotech company developing next-generation bioelectric therapeutics, today announced the launch of the LymeCure Research Study, a collaborative research effort with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback